The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of AXERT when treating
a migraine at the onset of headache pain, as compared to treating a migraine only after the
headache pain has reached at least moderate intensity..